Kantify develops smart solutions for lifesciences, healthcare and biotechnology.
Advancing Drug Discovery
Kantify has built a platform to accelerate the discovery of new drugs in silico. This next generation technology called ZeptoNet enables our pharma and biotech partners to improve target identification, hit discovery, hit optimization and ADMET optimization thanks to Artificial Intelligence. The technology has shown extremely promising results in several diseases including rare diseases.
Diagnosis and Clinical Decision Support
Kantify is developing AI solutions for diagnosis and clinical decision support. As a CRO, we help developing solutions in oncology, ophthalmology, hematology and other. Our expertise in AI for healthcare enables us to understand and tackle challenges in various therapeutical areas, using different datasets and sources.
Kantify is enabling life science organizations to accelerate the analysis of data, samples and other kind of clinical data thanks to Artificial Intelligence. Our expertise in several techniques within Artificial Intelligence enables us to tackle various kinds of data and technical challenges.
Artificial Intelligence in practice
Wed 22 Sep 2021
Detecting heart failure with AI: HeartKinetics and Kantify
Collaboration between Kantify and HeartKinetics around real-time detection and classification of heart failure
Thu 12 Aug 2021
AI for Breast Cancer Detection using whole-slide images
Step-by-step approach from data selection, cleaning and augmentation to training of a deep neural network for segmenting whole-slide images and counting nuclei.
Thu 17 Jun 2021
Diagnosing Endometrial Diseases from Tissue Images using AI
Discover how Artificial Intelligence can help diagnose endometrial diseases from tissue images
Thu 27 May 2021
Key AI Techniques in small molecule screening
Discover the key Artificial Intelligence techniques used for small molecule screening
Thu 15 Apr 2021
Draft EU regulation on AI and its impact on healthcare
We share an overview of the new concepts of the draft Regulation on a European Approach For Artificial Intelligence and the impact on AI based medical devices.
Fri 19 Mar 2021
ZeptoNet White Paper: AI for drug discovery
We present ZeptoNet, our novel machine learning technology for in silico small molecule screening at scale
Tue 23 Nov 2021
Kantify will host a webinar on AI and cardiology in practice
As a part of the webinar series on AI & Health, Kantify will host its next webinar titled AI in cardiology: detection and prediction of pathologies
Wed 17 Nov 2021
Meet us at Science for Health 2021
Kantify as an exhibitor on this year’s Science for Health event lead by flanders.bio